NDC 55154-5380
Levothyroxine Sodium 50 ug tablet
On the label: Cardinal Health 107, LLC. It's repackaged: Cardinal Health 107, LLC rebottles it from Mylan Institutional Inc.'s NDC 51079-440.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Mylan Institutional Inc. names for other drugs.
Recalls
- Mar 7, 2025 · Class II · Mylan Institutional, Inc.
Super-Potent Drug: Out of specification potency results were obtained.
Lots: Lot 3116074, Exp. 09/30/2025 - Mar 7, 2025 · Class II · Mylan Institutional, Inc.
Super-Potent Drug: Out of specification potency results were obtained.
Lots: Lot 3115773, Exp. 03/31/2025 - Nov 19, 2024 · Class II · Mylan Institutional, Inc.
Subpotent and Superpotent Drug
Lots: Lot #: 3115936, Exp. Date 07/2025 - Nov 19, 2024 · Class II · Mylan Institutional, Inc.
Subpotent and Superpotent Drug
Lots: Lot #: 3115893, Exp. Date 6/2025 - Nov 19, 2024 · Class II · Mylan Institutional, Inc.
Subpotent and Superpotent Drug
Lots: Lot #: 3115924, Exp. Date 06/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Levothyroxine: every company that makes it
- Form
- tablet, oral
- Strength
- 50 ug
- Approval
- ANDA ANDA076187
- On the market since
- Oct 29, 2010
- Package NDCs
55154-5380-0- Official label
- DailyMed (National Library of Medicine), updated Jun 4, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?